US Stock MarketDetailed Quotes
CADL Candel Therapeutics
- 6.390
- -0.040-0.62%
Close Apr 26 16:00 ET
- 6.560
- +0.170+2.66%
Post 19:59 ET
187.53MMarket Cap-4877P/E (TTM)
6.600High6.020Low391.98KVolume6.510Open6.430Pre Close2.50MTurnover2.17%Turnover RatioLossP/E (Static)29.35MShares11.40052wk High14.72P/B115.37MFloat Cap0.66052wk Low--Dividend TTM18.05MShs Float14.780Historical High--Div YieldTTM9.02%Amplitude0.660Historical Low6.369Avg Price1Lot Size
Candel Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.99%-34.24M | -7.80%-7.42M | 6.14%-8.81M | -1.38%-7.2M | -34.35%-10.82M | -41.41%-31.42M | -31.44%-6.89M | -36.12%-9.38M | -59.16%-7.1M | -43.11%-8.05M |
| Net income from continuing operations | -101.87%-37.94M | -118.28%-11.1M | 2.91%-8.44M | -131.72%-9.61M | -906.29%-8.8M | 47.97%-18.79M | -418.48%-5.08M | 46.24%-8.69M | 75.71%-4.15M | 80.48%-874K |
| Operating gains losses | 94.58%-887K | 117.67%485K | -56.22%-578K | 97.10%-144K | 92.16%-650K | -249.39%-16.37M | 70.17%-2.74M | -104.48%-370K | ---4.97M | ---8.29M |
| Depreciation and amortization | 23.39%960K | 12.67%249K | 19.51%245K | 26.20%236K | 39.39%230K | 235.34%778K | 24.16%221K | 876.19%205K | 2,571.43%187K | 534.62%165K |
| Other non cash items | 13.07%666K | 10.76%175K | -0.58%170K | 4.49%163K | 51.92%158K | 675.00%589K | 777.78%158K | 800.00%171K | 721.05%156K | 420.00%104K |
| Change In working capital | -839.44%-525K | 2,349.30%1.6M | 26.78%-1.06M | 15.40%1.43M | -819.02%-2.5M | 108.11%71K | -103.44%-71K | -55.04%-1.45M | 427.18%1.24M | 121.34%347K |
| -Change in prepaid assets | 20.91%503K | 73,400.00%733K | 51.68%-649K | 47.12%1.15M | -174.57%-730K | 118.82%416K | -100.38%-1K | 45.27%-1.34M | 277.29%781K | 535.11%979K |
| -Change in payables and accrued expense | -592.31%-256K | 1,125.69%1.12M | -750.00%-299K | -6.29%566K | -235.58%-1.64M | -94.62%52K | -107.88%-109K | -95.34%46K | 299.34%604K | 55.63%-489K |
| -Change in other current assets | ---116K | --23K | --20K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in other current liabilities | 0.00%-464K | 0.82%-121K | -0.85%-118K | 0.00%-113K | 0.00%-112K | ---464K | ---122K | ---117K | ---113K | ---112K |
| -Change in other working capital | -386.57%-192K | -196.89%-156K | 61.29%-12K | 62.50%-12K | 61.29%-12K | -76.49%67K | -61.20%161K | 42.59%-31K | 40.74%-32K | -40.91%-31K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.99%-34.24M | -7.80%-7.42M | 6.14%-8.81M | -1.38%-7.2M | -34.35%-10.82M | -41.41%-31.42M | -31.44%-6.89M | -36.12%-9.38M | -59.16%-7.1M | -43.11%-8.05M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 78.41%-280K | 90.22%-27K | 52.09%-103K | 73.39%-169K | 111.11%19K | 29.32%-1.3M | 45.24%-276K | 45.15%-215K | 10.56%-635K | 25.33%-171K |
| Net PPE purchase and sale | 78.41%-280K | 90.22%-27K | 52.09%-103K | 73.39%-169K | 111.11%19K | 29.32%-1.3M | 45.24%-276K | 45.15%-215K | 10.56%-635K | 25.33%-171K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 78.41%-280K | 90.22%-27K | 52.09%-103K | 73.39%-169K | 111.11%19K | 29.32%-1.3M | 45.24%-276K | 45.15%-215K | 10.56%-635K | 25.33%-171K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.61%-121K | -436.11%-121K | 0 | 0 | 0 | -72.18%19.97M | 36K | 0 | -93.39%22K | 17,682.14%19.92M |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | --19.91M | --0 | --0 | --0 | --19.91M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | -86.24%64K | --36K | --0 | -93.39%22K | -94.64%6K |
| Net other financing activities | ---121K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.61%-121K | -436.11%-121K | --0 | --0 | --0 | -72.18%19.97M | --36K | --0 | -93.39%22K | 17,682.14%19.92M |
| Net cash flow | ||||||||||
| Beginning cash position | -15.34%70.32M | -44.16%43.25M | -40.08%52.16M | -37.18%59.52M | -15.34%70.32M | 135.19%83.07M | -12.79%77.45M | 251.87%87.05M | 220.40%94.76M | 135.19%83.07M |
| Current changes in cash | -171.90%-34.65M | -6.25%-7.57M | 7.17%-8.91M | 4.49%-7.36M | -192.37%-10.8M | -126.69%-12.74M | -24.09%-7.13M | -114.98%-9.6M | -59.43%-7.71M | 303.55%11.69M |
| End cash Position | -49.26%35.68M | -49.26%35.68M | -44.16%43.25M | -40.08%52.16M | -37.18%59.52M | -15.34%70.32M | -15.34%70.32M | -12.79%77.45M | 251.87%87.05M | 220.40%94.76M |
| Free cash flow | -6.07%-34.7M | -4.30%-7.47M | 7.17%-8.91M | 4.76%-7.36M | -33.23%-10.96M | -36.02%-32.72M | -24.71%-7.16M | -31.75%-9.6M | -49.58%-7.73M | -40.44%-8.22M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg